|
1
|
|
$39.2M
|
–
|
–
|
–
|
|
|
2
|
Cowen and Company
New York
|
$25.5M
|
–
|
–
|
–
|
|
|
3
|
Polar Capital Holdings
London,
United Kingdom
|
$21.9M
|
+$2.78M
|
+404,479
|
+14%
|
|
|
4
|
Brandes Investment Partners
La Jolla,
California
|
$20.4M
|
+$2.67M
|
+389,041
|
+15%
|
|
|
5
|
Vivo Capital
Palo Alto,
California
|
$20.1M
|
–
|
–
|
–
|
|
|
6
|
|
$19.4M
|
+$2.69M
|
+391,132
|
+16%
|
|
|
7
|
Wealth Effects
Boston,
Massachusetts
|
$16.2M
|
+$497K
|
+72,273
|
+3%
|
|
|
8
|
Woodline Partners
San Francisco,
California
|
$14.5M
|
-$1.01M
|
-146,973
|
-6%
|
|
|
9
|
Avoro Capital Advisors
New York
|
$11.4M
|
–
|
–
|
–
|
|
|
10
|
Janus Henderson Group
London,
|
$9.63M
|
+$2.8M
|
+407,069
|
+41%
|
|
|
11
|
International Biotechnology Trust
London,
United Kingdom
|
$7.65M
|
+$344K
|
+50,000
|
New
|
|
|
12
|
Frazier Life Sciences Management
Palo Alto,
California
|
$6.5M
|
+$6.54M
|
+951,814
|
New
|
|
|
13
|
Renaissance Technologies
New York
|
$5.15M
|
-$629K
|
-91,500
|
-11%
|
|
|
14
|
Samsara BioCapital
Palo Alto,
California
|
$4.5M
|
–
|
–
|
–
|
|
|
15
|
Acuta Capital Partners
Redwood City,
California
|
$3.96M
|
+$3.99M
|
+580,000
|
New
|
|
|
16
|
MPM BioImpact
Boston,
Massachusetts
|
$2.82M
|
+$255K
|
+37,037
|
+10%
|
|
|
17
|
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$2.35M
|
–
|
–
|
–
|
|
|
18
|
|
$2.34M
|
-$785K
|
-114,255
|
-25%
|
|
|
19
|
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$1.78M
|
+$287K
|
+41,813
|
+19%
|
|
|
20
|
Bank of America
Charlotte,
North Carolina
|
$1.62M
|
+$1.17M
|
+170,136
|
+253%
|
|
|
21
|
|
$1.42M
|
-$347K
|
-50,535
|
-20%
|
|
|
22
|
State Street
Boston,
Massachusetts
|
$1.41M
|
+$112K
|
+16,278
|
+9%
|
|
|
23
|
Laurion Capital Management
New York
|
$1.24M
|
+$1.25M
|
+182,000
|
New
|
|
|
24
|
Lazard Asset Management
New York
|
$998K
|
-$79K
|
-11,495
|
-7%
|
|
|
25
|
Edge Wealth Management
New York
|
$990K
|
–
|
–
|
–
|
|
